ATAI Life Sciences Files 2024 10-K, Details Financials
Ticker: ATAI · Form: 10-K · Filed: Mar 17, 2025 · CIK: 1840904
| Field | Detail |
|---|---|
| Company | Atai Life Sciences N.V. (ATAI) |
| Form Type | 10-K |
| Filed Date | Mar 17, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceuticals, mental-health, financials
TL;DR
ATAI filed its 2024 10-K. Financials and strategy details out.
AI Summary
ATAI Life Sciences N.V. filed its 2024 10-K on March 17, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on mental health treatments, disclosed details about its financial position, business operations, and forward-looking strategies. Key events mentioned include amendments to the Gaba PSPA and potential warrant exercises related to Term Loan Warrants as of March 31, 2024.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of ATAI Life Sciences' financial health and strategic direction for the past fiscal year, crucial for understanding the company's progress in the mental health therapeutics sector.
Risk Assessment
Risk Level: medium — The filing covers a company in the pharmaceutical sector, which inherently involves significant research and development risks, regulatory hurdles, and market competition.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 1231 — Fiscal Year End (Indicates the end of the reporting period)
- 20250317 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- ATAI Life Sciences N.V. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-03-17 (date) — Filing date
- Gaba PSPA (document) — Amended agreement mentioned
- Term Loan Warrants (financial_instrument) — Related to warrant exercises
FAQ
What is the primary business of ATAI Life Sciences N.V.?
ATAI Life Sciences N.V. is focused on mental health treatments, as indicated by its SIC code for Pharmaceutical Preparations and its business context.
When did ATAI Life Sciences N.V. change its former name?
The company formerly known as ATAI Life Sciences B.V. changed its name on January 15, 2021.
What is the business address of ATAI Life Sciences N.V.?
The business address is Wallstrasse 16, Berlin, 10179.
What specific financial instruments or agreements are mentioned in relation to the fiscal year 2024?
The filing mentions amendments to the Gaba PSPA and Term Loan Warrants, with a date of March 31, 2024, associated with the latter.
What is the SEC file number for ATAI Life Sciences N.V.?
The SEC file number is 001-40493.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 17, 2025 regarding ATAI Life Sciences N.V. (ATAI).